The pricing of an IPO can have a significant impact on a company's stock price. In this case, Lexeo Therapeutics has priced its IPO at $11.00 per share. This could potentially attract investors, leading to an increase in demand for the stock and potentially impacting its price. However, it's also possible that the market may react differently, leading to a decrease in the stock price. Therefore, the short-term impact on the stock price is uncertain.